Table 1. Demographic and clinical data in 85 patients investigated for TB.
| Patient Category | Female gender n(%) | Age median (range) | BCG n(%) | Origin n(%) Low-High- endemicendemic | Immune-suppressionn (%) | HIV+/HIV tested n(%) | Culture+or PCR+ n(%) | TST+/TST tested n(%) |
| Pulm TB n = 25 | 12 (48) | 34 (17–66) | 17 (68) | 9 (36)16 (64) | 7 (20) | 2/19 (11) | 25 (100) | 14/16 (93) |
| ExpulmTB n = 18 | 13 (72) | 39 (19–67) | 8 (44) | 4 (22)14 (78) | 3 (17) | 0/14 (0) | 15 (83) | 12/12 (100) |
| Clinical TB n = 11 | 8 (73) | 43 (20–79) | 5(45) | 8 (73)3 (27) | 5 (45) | 0/6(0) | 0 (0) | 7/8 (88) |
| Non TBn = 8 | 5 (63) | 47 (23–76) | 5 (63) | 4 (50)4 (50) | 0 (0) | 0/4 (0) | - | 0/11 (0) |
| Latent TB n = 23 | 11 (48) | 44 (20–67) | 18 (78) | 14 (61)9 (39) | 6 (26) | 0/5 (0) | - | 23/23 (100) |
Values given are the number of patients in each category (percentage in parentheses). Female gender is given. Low TB-endemic origin incidence ≤1/100000, High TB-endemic origin incidence >100/100000. Immunosuppression includes potentially immunosuppressive conditions such as diabetes mellitus, treatment with immunosuppressant drugs, transplantation, renal insufficiency, rheumatic diseases, alcoholism and pregnancy.